您的位置: 首页 > 农业专利 > 详情页

RÉDUCTION DES NIVEAUX DE GALECTINE PAR PLASMAPHÉRÈSE
专利权人:
ELIAZ THERAPEUTICS; INC.
发明人:
申请号:
EP16184096.2
公开号:
EP3151009A1
申请日:
2012.09.28
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
A galectin-1, 9, 2, 4, 5, 6, 7, 8, 10, 11, 12, 13, 14 or 15 binding molecule for use in a method of treating a condition in a mammal mediated at least in part by active said galectin in the blood, comprising: selecting a mammal in need of reduction of circulating levels of said galectin; and conducting plasmapheresis on the blood of said mammal to reduce circulating levels of active said galectin, wherein said plasmapheresis is conducted so as to selectively remove said galectin by contact with said galectin binding molecule, such that at least ten percent of the circulating said galectin in the serum of that individual is removed by said plasmapheresis.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充